JPRN-UMIN000037604CompletedPhase 4
Efficacy Ezetimibe for dyslipidemia: A prospective cohort study - Efficacy Ezetimibe for dyslipidemia: A prospective cohort study
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Sekino Hospital
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who were deemed not appropriate to participate in this study by doctor
Investigators
Similar Trials
Completed
Not Applicable
Effect of ezetimibe in hypercholesterolemic patient with glucose toleranceDyslipidemiaJPRN-UMIN000004091Chigasaki Municipal Hospital150
Completed
Not Applicable
The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)onaicoholic fatty liver diseaseJPRN-UMIN000002440Saiseikai Suita Hospital50
Completed
Not Applicable
Effect of ezetimibe on small dense LDL and fatty acids in patients treated with a statin and omega-3 fatty acids supplimentatioDyslipidemiaJPRN-UMIN000012589Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences30
Completed
Not Applicable
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE TrialAtherosclerotic Cardiovascular DiseaseNCT04626973Yonsei University3,048
Completed
Not Applicable
Ezetimibe lipid lowering trial on cholesterol absorption-synthesis and prevention of atherrosclerosis in 75 or older with hight risk hyper LDL cholesterolemiaHyper-LDL-cholesterolemiaJPRN-UMIN000017769International University of Health and Welfare1,300